NCT07116395View on ClinicalTrials.gov

Prospective Study: TXA, Anticoagulant, Orthopaedic Trauma

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

June 30, 2029

Study Completion Date

December 31, 2030

Conditions
Patients Undergoing Operative Fixation of Long Bone Fractures Within the Community Medical Centers System
Interventions
DRUG

Tranexamic Acid (TXA)

orthopedic trauma patients who are on anticoagulation

Trial Locations (1)

93701

Community Regional Medical Center, Fresno

All Listed Sponsors
collaborator

Inspire Health Medical Group

UNKNOWN

lead

Arbi Nazarian, MD

OTHER